Trubion Pharmaceuticals, Inc

• Accepted (ET)
• Feb 7SC 13G/A—
  Trubion Pharmaceuticals, Inc0001072613-11-000077 · 69.3 KB
  SEC(opens sec.gov)
• Oct 298-K—
  Current report0001367644-10-000047 · 49.6 KB
  SEC(opens sec.gov)
• Oct 88-K—
  Current report0000950123-10-092365 · 36.6 KB
  SEC(opens sec.gov)
• Sep 308-K—
  Current report0000950123-10-090448 · 31.6 KB
  SEC(opens sec.gov)
• Sep 27SC 13G/A—
  Trubion Pharmaceuticals, Inc0001104659-10-050053 · 66.8 KB
  SEC(opens sec.gov)
• Sep 274—
  Insider trades0001104659-10-050051 · 6.2 KB
  SEC(opens sec.gov)
• Sep 10SC 13G/A—
  Trubion Pharmaceuticals, Inc0000315066-10-003311 · 6.7 KB
  SEC(opens sec.gov)
• Sep 88-K—
  Current report0000950123-10-084614 · 22.0 KB
  SEC(opens sec.gov)
• Aug 24SC 13G/A—
  Trubion Pharmaceuticals, Inc0001325447-10-000038 · 8.4 KB
  SEC(opens sec.gov)
• Aug 23SC 13D—
  Trubion Pharmaceuticals, Inc0000950123-10-079964 · 53.5 KB
  SEC(opens sec.gov)

• ABBOTT BIOTHERAPEUTICS CORP10% Owner
• ABBOTT LABORATORIES10% Owner
• ARCH V ENTREPRENEURS FUND LP10% Owner
• ARCH VENTURE FUND V LP10% Owner
• Bencich JohnV.P. and CFO
• Brettman Lee RDirector
• BYBEE CLINTON10% Owner
• CRANDELL KEITH10% Owner
• FHM IV LLC10% Owner
• FRAZIER HEALTHCARE IV LP10% Owner

No tickers on record.

• business

  2401 4TH AVENUE SUITE 1050

  SEATTLE, WA, 98121

• mailing

  2401 4TH AVENUE SUITE 1050

  SEATTLE, WA, 98121